DARA BioSciences (DARA) Tops Q2 EPS by 1c

DARA BioSciences (NASDAQ: DARA) reported Q2 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $990.8 thousand versus the consensus estimate of $760 thousand.

For earnings history and earnings-related data on DARA BioSciences (DARA) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c